About
Guangzhou Pharmaceutical Holdings Limited (GPHL) is a wholly state-owned enterprise authorized by Guangzhou municipal government to operate state-owned assets. GPHL is dedicated to the research and development of Chinese patent medicine, Chinese herbal medicine, chemical pharmaceutical raw materials and preparations, biological medicine and healthcare products, and to pharmaceutical logistics and distribution and healthcare service. As a large enterprise winning the municipal government's key support for development, GPHL integrates the research, manufacturing and trading of medicine. It consists of one public company, namely Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd., which is listed both at the Stock Exchange of Hong Kong Limited (H-Shares) and the Shanghai Stock Exchange (A-Shares), and around 30 subsidiaries.
Position in the VCSift Database
- • 4,609 investors in VCSift focus on the biotech sector.
- • 225 investors are based in Guangzhou, Guangdong, China.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- biotech
- Location
- Guangzhou, China
Contact Information
Find more investors like Guangzhou
Search Investors